tacrolimus
Astellas Joins U.S. Most Favored Nation Pricing Program
Astellas Pharma Inc. (TSE: 4503) announced on August 31 that it has entered a voluntary drug pricing agreement with the U.S. government. The release itself is unusually thin on specifics, disclosing just two actions and stating plainly that additional terms are not being disclosed, so this article draws on independent reporting to explain what program…
